Biblio

Author Title Type [ Year(Desc)]
Filters: First Letter Of Title is H  [Clear All Filters]
2014
Lant B, W Derry B. High-Throughput RNAi Screening for Germline Apoptosis Genes in Caenorhabditis elegans. Cold Spring Harb Protoc. 2014;2014(4).
Incarnato D, Krepelova A, Neri F. High-throughput single nucleotide variants discovery in E14 mouse embryonic stem cells provides a new reference genome assembly. Genomics. 2014.
Cuervo B, Rubio M, Sopena J, Dominguez JManuel, Vilar J, Morales M, Cugat R, Carrillo JMaria. Hip Osteoarthritis in Dogs: A Randomized Study Using Mesenchymal Stem Cells from Adipose Tissue and Plasma Rich in Growth Factors. Int J Mol Sci. 2014;15(8):13437-13460.
Yimlamai D, Christodoulou C, Galli GG, Yanger K, Pepe-Mooney B, Gurung B, Shrestha K, Cahan P, Stanger BZ, Camargo FD. Hippo Pathway Activity Influences Liver Cell Fate. Cell. 2014;157(6):1324-1338.
Wicklow E, Blij S, Frum T, Hirate Y, Lang RA, Sasaki H, Ralston A. HIPPO Pathway Members Restrict SOX2 to the Inner Cell Mass Where It Promotes ICM Fates in the Mouse Blastocyst. PLoS Genet. 2014;10(10):e1004618.
Serafini G, Hayley S, Pompili M, Dwivedi Y, Brahmachari G, Girardi P, Amore M. Hippocampal neurogenesis, neurotrophic factors and depression: possible therapeutic targets?. CNS Neurol Disord Drug Targets. 2014.
Lange AW, Sridharan A, Xu Y, Stripp BR, Perl A-K, Whitsett JA. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung. J Mol Cell Biol. 2014.
Sun Y, Yong KMeng Aw, Villa-Diaz LG, Zhang X, Chen W, Philson R, Weng S, Xu H, Krebsbach PH, Fu J. Hippo/YAP-mediated rigidity-dependent motor neuron differentiation of human pluripotent stem cells. Nat Mater. 2014.
Jung G, Bernstein D. hiPSC Modeling of Inherited Cardiomyopathies. Curr Treat Options Cardiovasc Med. 2014;16(7):320.
Moazzami F, Ghahramani Y, Tamaddon AMohammad, Nazhavani ADehghani, Adl A. A histological comparison of a new pulp capping material and mineral trioxide aggregate in rat molars. Iran Endod J. 2014;9(1):50-5.
Lv W, Guo X, Wang G, Xu Y, Kang J. Histone Deacetylase 1 and 3 Regulate the Mesodermal Lineage Commitment of Mouse Embryonic Stem Cells. PLoS One. 2014;9(11):e113262.
Chen D-Q, Huang J-Y, Feng B, Pan B-Z, De W, Wang R, Chen L-B. Histone Deacetylase 1/Sp1/MicroRNA-200b Signaling Accounts for Maintenance of Cancer Stem-Like Cells in Human Lung Adenocarcinoma. PLoS One. 2014;9(10):e109578.
Dudakovic A, Camilleri ET, Lewallen EA, McGee-Lawrence ME, Riester SM, Kakar S, Montecino M, Stein GS, Ryoo H-M, Dietz AB, et al. Histone deacetylase inhibition destabilizes the multi-potent state of uncommitted adipose-derived mesenchymal stromal cells. J Cell Physiol. 2014.
Tomioka T, Maruoka H, Kawa H, Yamazoe R, Fujiki D, Shimoke K, Ikeuchi T. The histone deacetylase inhibitor trichostatin A induces neurite outgrowth in PC12 cells via the epigenetically regulated expression of the nur77 gene. Neurosci Res. 2014.
Kondo Y, Iwao T, Yoshihashi S, Mimori K, Ogihara R, Nagata K, Kurose K, Saito M, Niwa T, Suzuki T, et al. Histone Deacetylase Inhibitor Valproic Acid Promotes the Differentiation of Human Induced Pluripotent Stem Cells into Hepatocyte-Like Cells. PLoS One. 2014;9(8):e104010.
Consalvi S, Saccone V, Mozzetta C. Histone deacetylase inhibitors: a potential epigenetic treatment for Duchenne muscular dystrophy. Epigenomics. 2014;6(5):547-560.
Farifteh F, Salehi M, Bandehpour M, Nariman M, Novin MGhafari, Hosseini T, Nematollahi S, Noroozian M, Keshavarzi S, Hosseini A. Histone Modification of Embryonic Stem Cells Produced by Somatic Cell Nuclear Transfer and Fertilized Blastocysts. Cell J. 2014;15(4):316-323.
Wu T, Liu Y, Wen D, Tseng Z, Tahmasian M, Zhong M, Rafii S, Stadtfeld M, Hochedlinger K, Xiao A. Histone Variant H2A.X Deposition Pattern Serves as a Functional Epigenetic Mark for Distinguishing the Developmental Potentials of iPSCs. Cell Stem Cell. 2014;15(3):281-294.
Green MR, Vicente-Dueñas C, Alizadeh AA, Sánchez-García I. Hit-and-run lymphomagenesis by the Bcl6 oncogene. Cell Cycle. 2014;13(12).
Sax PE, Sypek A, Berkowitz BK, Morris BL, Losina E, A Paltiel D, Kelly KA, Seage GR, Walensky RP, Weinstein MC, et al. HIV Cure Strategies: How Good Must They Be to Improve on Current Antiretroviral Therapy?. PLoS One. 2014;9(11):e113031.
Krishnan A, Zaia JA. HIV-associated non-Hodgkin lymphoma: viral origins and therapeutic options. Hematology Am Soc Hematol Educ Program. 2014;2014(1):584-589.
Gragert L, Eapen M, Williams E, Freeman J, Spellman S, Baitty R, Hartzman R, J Rizzo D, Horowitz M, Confer D, et al. HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry. N Engl J Med. 2014;371(4):339-348.
Locafaro G, Amodio G, Tomasoni D, Tresoldi C, Ciceri F, Gregori S. HLA-G Expression on Blasts and Tolerogenic Cells in Patients Affected by Acute Myeloid Leukemia. J Immunol Res. 2014;2014:636292.
Puca F, Colamaio M, Federico A, Gemei M, Tosti N, Bastos AUchimura, Del Vecchio L, Pece S, Battista S, Fusco A. HMGA1 silencing restores normal stem cell characteristics in colon cancer stem cells by increasing p53 levels. Oncotarget. 2014.
Boland EG, Boland JW, Ezaydi Y, Greenfield DM, Ahmedzai SH, Snowden JA. Holistic needs assessment in advanced, intensively treated multiple myeloma patients. Support Care Cancer. 2014.

Pages